Part ofHealth →

The civic record

Read. Follow. Verify.

HB 4392WEST VIRGINIASession 2026State Billdead

Did Not Advance

West Virginia Bill 4392 bans specific artificial food dyes and additives in drugs and foods

Original title: Banning certain dyes from pharmaceutical products

Last action · February 3, 2026: Markup DiscussionSponsor: Adam Burkhammer

Bill progressHistory & official text ↓

Introduced

Committee

Floor Vote

Passed

Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Proposed

Official description

Banning certain dyes from pharmaceutical products

Why it matters

Prohibits the sale of pharmaceutical and food products containing specified color additives deemed injurious to health, altering ingredient formulations for manufacturers distributing goods in West Virginia.

Who It Would Have Affected

Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.

Directly affected

pharmaceutical manufacturers

Must reformulate drug products distributed in West Virginia to exclude the newly banned artificial dyes.

Directly affected

food producers

Must remove specified chemical additives and dyes from food, drink, confectionery, and condiment products sold in the state.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

What specific dyes are prohibited by House Bill 4392?

The bill prohibits FD&C Blue No. 1, FD&C Blue No. 2, FD&C Green No. 3, FD&C Red No. 3, FD&C Red No. 40, FD&C Yellow No. 5, and FD&C Yellow No. 6 in drugs, and includes these alongside butylated hydroxyanisole and propylparaben in foods.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Follow the record

Votes, people, money & the original source

Where This Stands

This bill did not become law - Died at adjournment · in House committee.

Procedural history

5 actions

Feb 3, 2026House
Markup Discussion
Jan 15, 2026HouseCommittee
To House Health and Human Resources
Jan 15, 2026HouseIntroduced
Introduced in House
Jan 15, 2026HouseCommittee
To Health and Human Resources
Jan 15, 2026HouseIntroduced
Filed for introduction

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Connected Entities

National Formulary, Committee on Health and Human Resources, Adam Burkhammer and 1 more

OrganizationNational Formulary“Standard reference work recognized for drugs”Map →

OrganizationCommittee on Health and Human Resources“House committee to which the bill was referred”Map →

PersonAdam Burkhammer“Delegate who introduced House Bill 4392”Map →

OrganizationUnited States Pharmacopoeia“Standard reference work for drug strength, quality, and purity”Map →

Sources

Open source document

www.wvlegislature.gov

Analysis Score

0–100

Significance20
Lowered because this bill did not pass (its text scored 60)
Controversy50
Intensity of disagreement among stakeholders
Entertainment10
Compellingness for a non-policy-wonk reader
Buzz35
Current news / social attention level

Publisher tools